3rd April 2020|Commercial Media, News ProBiotix Health CholBiome®X3 shortlisted in the Nutraingredients Awards 2020
30th March 2020|Commercial Media, News OptiBiotix extends East European sales of GoFigure® with distribution partner Extensor
18th March 2020|Investor Media, News OptiBiotix partners with Prosperous Pharma to bring SlimBiome® Medical to the Middle East
18th March 2020|Investor Media, News OptiBiotix launches contemporary new SlimBiome® website to support customers in the Philippines
16th March 2020|Investor Media, News ProBiotix Health partners with Velinoff Pharma to bring CholBiome® and CholBiome® X3 to Bulgarian market
16th March 2020|Investor Media, News ProBiotix Health extends agreement with Sacco S.r.l. for the manufacturing and supply of its patented probiotic strain LPLDL until 2023
5th March 2020|Investor Media, News A Thriving Partnership: OptiBiotix meets with Maxum Foods in Australia to continue SlimBiome® success
20th February 2020|Investor Media, News OptiBiotix partners with Select Ingredient to bring its patented probiotic strain LPLDL to the US and Canadian markets
